M S Hertzberg
Overview
Explore the profile of M S Hertzberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Satwani P, Ahn K, Carreras J, Abdel-Azim H, Cairo M, Cashen A, et al.
Bone Marrow Transplant
. 2015 Aug;
50(11):1416-23.
PMID: 26237164
Autologous hematopoietic cell transplantation (AutoHCT) is a potentially curative treatment modality for relapsed/refractory Hodgkin lymphoma (HL). However, no large studies have evaluated pretransplant factors predictive of outcomes of AutoHCT in...
2.
George B, Kerridge I, Gilroy N, Huang G, Hertzberg M, Bradstock K, et al.
Transpl Infect Dis
. 2012 Jan;
14(2):141-8.
PMID: 22283838
Background: This retrospective study was aimed at establishing a clinical score to stratify the risk of cytomegalovirus (CMV) reactivation in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) in order...
3.
George B, Benson W, Hertzberg M
Bone Marrow Transplant
. 2011 Oct;
47(7):1001-2.
PMID: 22002487
No abstract available.
4.
Bradstock K, Hertzberg M, Kerridge I, Svennilson J, McGurgan M, Huang G, et al.
Intern Med J
. 2006 May;
36(6):355-61.
PMID: 16732860
Background: A number of haematological malignancies can be cured by allogeneic stem cell transplantation but only approximately 30% of Australians have a suitable histocompatible related donor. Matched donors can be...
5.
Hertzberg M, Crombie C, Benson W, Taper J, Gottlieb D, Bradstock K
Ann Oncol
. 2006 May;
17 Suppl 4:iv25-30.
PMID: 16702181
We have treated 75 transplant-eligible patients with relapsed or refractory lymphoma using an outpatient-based fractionated regimen of ifosfamide, carboplatin and etoposide (ICE) for both salvage and stem cell mobilisation. Patients...
6.
Hertzberg M, Mammen J, McCraw A, Nair S, Srivastava A
Haemophilia
. 2006 May;
12 Suppl 3:61-7.
PMID: 16683998
In order to ensure the delivery of a service of the highest possible quality, it is an essential requirement that laboratories undertake strict internal quality control (QC) measures as well...
7.
Erdstein A, Daas P, Bradstock K, Robinson T, Hertzberg M
Transpl Infect Dis
. 2005 Mar;
6(4):142-6.
PMID: 15762931
Allogeneic stem cell transplant (ASCT) recipients have severely impaired cell-mediated immunity as a result of their conditioning regimen, immunosuppressive therapy, and graft-versus-host disease (GVHD). Accordingly, they are susceptible to bacterial,...
8.
Ramanathan S, Koutts J, Hertzberg M
Am J Hematol
. 2005 Feb;
78(2):123-6.
PMID: 15682420
Autoimmune hemolytic anemia is thought to be mediated via auto-antibodies produced by lymphoid B cells. This may be an idiopathic process or secondary to an underlying infection or lymphoproliferative disorder....
9.
Hertzberg M, Crombie C, Benson W, Taper J, Gottlieb D, Bradstock K
Ann Oncol
. 2003 May;
14 Suppl 1:i11-6.
PMID: 12736225
We have treated 38 transplant-eligible patients with relapsed/refractory non-Hodgkin's lymphoma and Hodgkin's disease using an outpatient-based regimen of ifosfamide, carboplatin and etoposide (ICE) for both salvage and peripheral blood stem...
10.
Gilbert A, Fleming P, Hertzberg M
Hemoglobin
. 2000 Jun;
24(2):163-4.
PMID: 10870890
No abstract available.